Epigenetics Growth Zymo Research is a recognized leader in epigenetics with a rapidly expanding product portfolio and a strong history of epigenetics patentable technologies, presenting cross-sell opportunities for related DNA and RNA purification tools, enzymes, and analytical services.

Collaborations & Partnerships Recent partnerships with Stori for cell-free DNA pregnancy testing and the launch of Zymo Services indicate a strategy of co-development and service-driven offerings that can create joint sales motions with healthcare, diagnostics, and contract research organizations.

New Platform Rollout The introduction of initiatives like Zymo Services and the MultiOmiX Workstation signals a shift toward integrated workflows and high-throughput solutions, offering opportunities to upsell bundled systems, consumables, and support services to labs expanding their genomics capabilities.

Industry Engagement Active participation in industry events such as the Microbes in Wastewater Symposium positions Zymo as a supplier of wastewater surveillance tools, opening sales avenues with public health agencies, water utilities, and environmental monitoring labs.

Financial Scale & Reach With a mid-market revenue range and a sizable employee base, Zymo Research has the scale to pursue channel partnerships, regional distributors, and OEM collaborations to expand geographic footprint and accelerate adoption of existing and new nucleic acid purification and sequencing-ready products.